Lupus & antiphospholipid syndrome

Right ventricular-pulmonary arterial coupling ratio derived from 3-dimensional echocardiography predicts outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension patients

LupusPublished Prospective cohort study

Authors' conclusion

The 3DE-derived SV/ESV ratio as a noninvasive alternative surrogate of RV-PA coupling was an eximious indicator for identifying endpoint events in SLE-PAH patients

Study context

Population
Consecutive patients with SLE-PAH, June 2019 to February 2023
Participants
46 SLE-PAH patients
Exposure
SLE-PAH patients vs healthy controls; RVSV/right ventricular end-systolic volume (RVESV) ratio by 3DE
  • Controlsn = 30reference
  • SLE-PAH with endpoint eventn = 16
Outcome
Composite of:
  • All-cause mortality
  • Adverse clinical events
Methodological detailsconsecutive enrolment, healthy controls matched for age, sex and body surface area (BSA)
  • Consecutive enrolment
  • Healthy controls matched for age, sex and BSA

Main finding

As reported in the abstract

Endpoint-related events · median 24 months (IQR 18-31)

SLE-PAH with endpoint event

34.7%

16

Observational data: associations, not effects.

Further findings

OutcomeControlsSLE-PAH without endpoint eventSLE-PAH with endpoint eventP value
RVSV/RVESV ratioSLE-PAH with endpoint event vs Controls · three-group comparison1.86 (range 1.65–2.3)1.30 (range 1.09–1.46)0.64 (range 0.59–0.67)P < 0.001

Correlation of RVSV/RVESV ratio with WHO FC

Negative correlation (r)
−0.621
P
P < 0.001
Positively correlated with anti-dsDNA level

Prognostic cutoff of RVSV/RVESV (ROC)

Optimal cutoff; RVSV/RVESV < 0.712 higher risk of poor prognosis
Kaplan-Meier: ratio >0.712 associated with more favourable long-term outcomes

Original publication

Right ventricular-pulmonary arterial coupling ratio derived from 3-dimensional echocardiography predicts outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension patients. Lupus. Published 5 January 2024. doi:10.1177/09612033231226352

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.